This channel includes news on cardiovascular care delivery, including how patients are diagnosed and treated, cardiac care guidelines, policies or legislation impacting patient care, device recalls that may impact patient care, and cardiology practice management.
A multidisciplinary research team has found a new use for a reliable medical device. Multiple heart patients have already benefited for the group’s outside-the-box thinking.
The high-risk patients who require urgent or emergent TAVR are often excluded from major clinical trials. To learn more about this population, researchers explored data from nearly 600 patients treated at high-volume facilities.
U.S. healthcare will know it’s gotten AI right when the technology demonstrably improves care access, attentiveness and outcomes for the least financially healthy among us.
A primary aim of medical humanities as a field today is teaching medical students how to harmonize technological innovations with care models such that patients are treated as whole persons: They have not just bodies but also minds, relationships—and lives.
Federal lawmakers have a fresh resource to keep them up on healthcare AI that falls outside of formal FDA oversight. It comes in the form of a new report from the nonprofit Bipartisan Policy Center.
Patients who frequently use AI tend to readily trust AI-assisted diagnoses made by their physicians. Counterintuitively, however, those who would rank themselves among the very best-informed about AI tend to mistrust such diagnoses.
The device covers three vessels at once and can be deployed through the patient's TAVR access site. Researchers shared their first-in-human experience in JACC: Case Reports.
The group highlighted the proven effectiveness of these drugs, especially semaglutide and tirzepatide, while noting that eligibility, affordability and availability will still play key roles in any treatment decisions.